Month: September 2025

Iconic All-American Burger Chain to Open Four Locations in Okinawa Over The Next Five Years LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc., parent company of Fatburger and 17 other restaurant concepts, announces a new partnership with Green Micro Factory Inc. to bring the beloved burger brand back to Japan. Four locations will open in Okinawa over the next five years, with the first unit slated to open before the end of the year. “Okinawa presents a strategic opportunity for our return to Japan with its robust tourism and steady foot traffic generated by its military base presence,” said Taylor Wiederhorn, Chief Development Officer of FAT Brands. “We see our debut in Okinawa as the first step in our broader growth across the country as we look to win locals over with our custom-built burgers,...

SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that the partners of Tennant Financial have joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. They reported serving approximately $1.3 billion in advisory, brokerage and retirement plan assets* and join LPL from Northwestern Mutual. Based in Ballston Lake, near Saratoga Springs, N.Y., the team led by Steven Tennant, CFP®, Jeremy Berry, CPA and Ryan Wade, MBA, CFA®, provides financial services to clients throughout New England and nationwide. The three have collaborated since 2000 and together have 75 years of financial services and investment planning experience. The team primarily serves high-net-worth families, corporate executives, business owners, and medical professionals, as well as individuals navigating life...

Company Successfully Meets Both Minimum Bid Price and Shareholders’ Equity Requirements, Securing Continued Listing on the Nasdaq Capital Market GRAND CAYMAN, Cayman Islands, Sept. 25, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company“), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that it has received written notification from The Nasdaq Stock Market LLC (“Nasdaq“) confirming that the Company has regained compliance with both Nasdaq Listing Rules 5550(a)(2) and 5550(b)(1), concerning the minimum bid price and shareholders’ equity requirements. The letter, dated September 23, 2025, confirmed that the Company has successfully met the minimum bid price requirement...

Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is the third-largest pharmaceutical market globally, with oncology as the fastest-growing therapeutic area OCALA, Fla., Sept. 25, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Japan Patent Office has issued a patent covering the Company’s proprietary use of Ampligen® (Rintatolimod) in combination with checkpoint inhibitors (anti-PD-1 or anti-PD-L1 antibodies) for the treatment of cancer. “We remain committed to strengthening our global intellectual property protection for Ampligen as we continue to advance its clinical development. This Japan patent – which does not expire until December 20, 2039 –...

Company to deliver oral and poster presentations for data on leronlimab’s action on PD-L1 expression and patient survival in triple-negative breast cancer VANCOUVER, Washington, Sept. 25, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including triple-negative breast cancer (TNBC) and colorectal cancer (CRC), will present a poster and an oral presentation at the AACR Special Conference in Cancer Research: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity, taking place September 24, to September 27, 2025, in Montreal, Canada. Metastatic triple-negative breast cancer (mTNBC) is...

MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) — NioBay Metals Inc. (“NioBay” or the “Company“) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce the appointment of the first members of its Technical Advisory Committee. This committee will assist the Board of Directors and management in the next phases of the Company’s development. These first members represent fields as varied as academia, geology, metallurgy, and Indigenous relations, as well as knowledge of the niobium market. We believe that the addition of this committee will allow NioBay to increase its credibility with the market and potential partners. This is a first round of appointments, and other members could join this committee by the end of the year, always with the aim of developing the Company’s bench strength in areas of relevant expertise. Members...

Beta version of PredicTcell™ expands training dataset to ~1.4 million and total dataset to over 6.7 billion records. Potential future T cell therapies could reliably bind to their target nearly every time, dramatically raising the probability of success.WARREN, N.J., Sept. 25, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced significant progress in the development of its proprietary PredicTcell™ platform, designed to accelerate precision immunotherapy development and efficacy through advanced machine learning and transformer-based models. The platform is being developed with the support of Microsoft (Nasdaq: MSFT) and Databricks, leveraging their advanced cloud and data technologies to enable scalability and efficiency. The alpha version of PredicTcell...

ATLANTA, Sept. 25, 2025 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company” or “Perma-Fix”) today announced that its founder and Executive Vice President of Strategic Initiatives, Dr. Louis Centofanti, has been awarded the Industry Innovation Award at the recent 2025 EI Digest Gathering in San Diego, California. The EI Digest Gathering is a premier executive-level conference focused on the commercial management of hazardous and universal wastes across North America. Dr. Centofanti received a standing ovation as he was recognized for nearly five decades of pioneering advancements that have redefined nuclear and hazardous waste treatment. Earlier in his career, Dr. Centofanti co-founded PPM, Inc., where he developed a first-of-its-kind process to destroy polychlorinated biphenyls (PCBs) in oil...